Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective PARP1 inhibitors, PARP1-based dual-target inhibitors, PROTAC PARP1 degraders, and prodrugs of PARP1 inhibitors for cancer therapy
Xiaopeng Peng, Wanyi Pan, Feng Jiang, et al.
Pharmacological Research (2022) Vol. 186, pp. 106529-106529
Closed Access | Times Cited: 21

Showing 21 citing articles:

PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 23
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
Viola Previtali, Greta Bagnolini, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11488-11521
Open Access | Times Cited: 7
Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system
Hanshu Xie, Chao Zhang
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116168-116168
Closed Access | Times Cited: 5
Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: Current progress and novel strategies
Deping Li, Xiaopeng Peng, Zhihao Hu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115982-115982
Closed Access | Times Cited: 12
Nuclear PARP1‐Targeted Photosensitizer as a Dual‐Mode DNA‐Damaging Agent and Immune Activator for Tumor Ablation
Peixia Li, Yayin Du, Jingru Qiu, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 31
Closed Access | Times Cited: 11
Discovery, Synthesis, and Evaluation of Novel Dual Inhibitors of a Vascular Endothelial Growth Factor Receptor and Poly(ADP-Ribose) Polymerase for BRCA Wild-Type Breast Cancer Therapy
Yang Li, Yun Liu, Dan Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12069-12100
Closed Access | Times Cited: 9
Design, synthesis, and biological evaluation of a series of benzofuran[3,2-d]pyrimidine-4(3H)-one derivatives containing thiosemicarbazone analogs as novel PARP-1 inhibitors
Yuanjiang Wang, Kun Li, Wenqing Xu, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106759-106759
Closed Access | Times Cited: 9
Discovery of novel benzamide derivatives bearing benzamidophenyl and phenylacetamidophenyl scaffolds as potential antitumor agents via targeting PARP-1
Guoqing Lu, Wenxing Nie, Meixiu Xin, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115243-115243
Closed Access | Times Cited: 8
Beyond monotherapy: An era ushering in combinations of PARP inhibitors with immune checkpoint inhibitors for solid tumors
Lin Zhou, Yicong Wan, Lin Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116733-116733
Open Access | Times Cited: 2
The novel lnc-HZ12 suppresses autophagy degradation of BBC3 by preventing its interactions with HSPA8 to induce trophoblast cell apoptosis
Jingsong Zhao, Zhongyan Xu, Jiayu Xie, et al.
Autophagy (2024) Vol. 20, Iss. 10, pp. 2255-2274
Closed Access | Times Cited: 2
Synthesis of 3-(Pyridin-2-yl)quinazolin-2,4(1H,3H)-diones via Annulation of Anthranilic Esters with N-pyridyl Ureas
Svetlana O. Baykova, Kirill K. Geyl, Sergey V. Baykov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7633-7633
Open Access | Times Cited: 7
Indirubin derivatives as bifunctional molecules inducing DNA damage and targeting PARP for the treatment of cancer
Siyuan Wan, Xinye Chen, Fucheng Yin, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115843-115843
Closed Access | Times Cited: 5
Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues
Marta Pichlak, Tomasz Sobierajski, K. M. Błażewska, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 3
Bibliometric analysis of research trends on the combination of immune checkpoint inhibitors and PARP inhibitors in solid tumors
Yaqian Tan, Qi Song
Heliyon (2024) Vol. 10, Iss. 2, pp. e24452-e24452
Open Access
Identification of diterpenoids from Salvia castanea Diels f. tomentosa Stib and their antitumor activities
Dongdong Wang, Rui Zhang, Lian-Yu Tang, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107701-107701
Closed Access
Co-Targeting of DTYMK and PARP1 as a Potential Therapeutic Approach in Uveal Melanoma
Sylwia Oziębło, Jakub Mizera, Agata Górska, et al.
Cells (2024) Vol. 13, Iss. 16, pp. 1348-1348
Open Access
Zhi Zhu Ma Ren pill relieves constipation in mice through endoplasmic reticulum stress-mediated apoptosis
Yong Wen, Yu Zhan, Jun Li, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 10, pp. 5829-5845
Closed Access
The Potential of PARP Inhibitors as Antitumor Drugs and the Perspective of Molecular Design
Yinghan Wang, Jingtao Zhang, Xiaochen Wu, et al.
Journal of Medicinal Chemistry (2024) Vol. 68, Iss. 1, pp. 18-48
Closed Access
Prudent tactics to sail the boat of PARP inhibitors as therapeutics for diverse malignancies
Mandeep Rana, Amandeep Thakur, Charanjit Kaur, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 10, pp. 1169-1193
Closed Access | Times Cited: 1
Design, Synthesis, and Biological Evaluation of a Series of Benzofuran [3,2-D]Pyrimidine-4(1h)-Ketone Derivatives Containing Thiosemicarbazone Analogs as Novel Parp-1 Inhibitors
Yuanjiang Wang, Kun Li, Wenqing Xu, et al.
(2023)
Closed Access
Targeted Protein Degraders- The Druggability Perspective
Satinder Singh, Pratima Srivastava
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 3, pp. 539-554
Closed Access
Page 1

Scroll to top